2015
A Double-Blind, Randomized, Sham-Controlled Trial of the Effect of a Radiation-Attenuating Drape on Radiation Exposure to Endoscopy Staff During ERCP
Muniraj T, Aslanian HR, Laine L, Farrell J, Ciarleglio MM, Deng Y, Ho H, Jamidar PA. A Double-Blind, Randomized, Sham-Controlled Trial of the Effect of a Radiation-Attenuating Drape on Radiation Exposure to Endoscopy Staff During ERCP. The American Journal Of Gastroenterology 2015, 110: 690. PMID: 25823765, DOI: 10.1038/ajg.2015.85.Peer-Reviewed Original ResearchConceptsEndoscopic retrograde cholangiopancreatographyTherapeutic endoscopic retrograde cholangiopancreatographyHigh-volume centersRadiation exposureEffective doseTertiary care university centerDouble-blind trialPrimary end pointRelative risk reductionDose area productEye levelAnnual radiation exposureRetrograde cholangiopancreatographyStudy groupEnd pointNeckDoseEndoscopistsRadiation doseEyesShamRisk reductionAnnual effective doseExposureArea product
2014
Psychosocial Characteristics and Pain Burden of Patients With Suspected Sphincter of Oddi Dysfunction in the EPISOD Multicenter Trial
Brawman-Mintzer O, Durkalski V, Wu Q, Romagnuolo J, Fogel E, Tarnasky P, Aliperti G, Freeman M, Kozarek R, Jamidar P, Wilcox M, Elta G, Orrell K, Wood A, Mauldin P, Serrano J, Drossman D, Robuck P, Cotton P. Psychosocial Characteristics and Pain Burden of Patients With Suspected Sphincter of Oddi Dysfunction in the EPISOD Multicenter Trial. The American Journal Of Gastroenterology 2014, 109: 436. PMID: 24445573, PMCID: PMC4409683, DOI: 10.1038/ajg.2013.467.Peer-Reviewed Original ResearchConceptsFunctional gastrointestinal disordersPain burdenOddi dysfunctionGender-matched general populationPainful functional gastrointestinal disordersFunctional gallbladder diseaseGreater pain burdenPost-cholecystectomy painHealth-related qualityMental composite scoreAnxiety/depressionBaseline anxiety scoresPsychosocial comorbiditiesMulticenter trialIrritable bowelGastrointestinal disordersGallbladder diseasePain descriptorsPsychosocial assessmentHigh prevalencePsychosocial parametersUS CentersStudy populationPsychosocial disturbancesSevere psychological problems
2005
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis
Mosler P, Sherman S, Marks J, Watkins JL, Geenen JE, Jamidar P, Fogel EL, Lazzell-Pannell L, Temkit M, Tarnasky P, Block KP, Frakes JT, Aziz AA, Malik P, Nickl N, Slivka A, Goff J, Lehman GA. Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis. Gastrointestinal Endoscopy 2005, 62: 245-250. PMID: 16046988, DOI: 10.1016/s0016-5107(05)01572-5.Peer-Reviewed Original ResearchConceptsPost-ERCP pancreatitisOral allopurinolAllopurinol groupControl groupOxygen-derived free radical productionPlacebo 4 hoursProcedure risk factorsCommon major complicationSeverity of pancreatitisFree radical productionProphylactic allopurinolPatient demographicsMajor complicationsOverall incidencePostprocedure pancreatitisPharmacologic agentsRisk factorsPancreatitisPatientsStandardized criteriaAllopurinolERCPSeveritySignificant differencesIncidence